These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16310279)

  • 1. Immunostimulatory CpG-oligodeoxynucleotides (CpG-ODN) induce early hepatic injury, but provide a late window for protection against endotoxin-mediated liver damage.
    Slotta JE; Scheuer C; Menger MD; Vollmar B
    J Hepatol; 2006 Mar; 44(3):576-85. PubMed ID: 16310279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
    Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
    Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis.
    Lu JW; Wang H; Yan-Li J; Zhang C; Ning H; Li XY; Zhang H; Duan ZH; Zhao L; Wei W; Xu DX
    J Hepatol; 2008 Mar; 48(3):442-52. PubMed ID: 18215436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel technique for selective NF-kappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion.
    Hoffmann F; Sass G; Zillies J; Zahler S; Tiegs G; Hartkorn A; Fuchs S; Wagner J; Winter G; Coester C; Gerbes AL; Vollmar AM
    Gut; 2009 Dec; 58(12):1670-8. PubMed ID: 19470497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
    Jahrsdörfer B; Wooldridge JE; Blackwell SE; Taylor CM; Griffith TS; Link BK; Weiner GJ
    J Leukoc Biol; 2005 Mar; 77(3):378-87. PubMed ID: 15582984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress.
    Hickson-Bick DL; Jones C; Buja LM
    Shock; 2006 May; 25(5):546-52. PubMed ID: 16680021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of CpG-ODN combined with HBsAg on the phenotype, function and the activity of NF-kappa B and AP-1 of monocyte-derived dendritic cells in chronic hepatitis B patients].
    Xiang XX; Zhou XQ; Xie Q; Yu H; Zhou HJ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Feb; 16(2):97-100. PubMed ID: 18304423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells.
    Xu FL; You HB; Li XH; Chen XF; Liu ZJ; Gong JP
    Am J Surg; 2008 Jul; 196(1):139-48. PubMed ID: 18565339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model.
    Ogushi I; Iimuro Y; Seki E; Son G; Hirano T; Hada T; Tsutsui H; Nakanishi K; Morishita R; Kaneda Y; Fujimoto J
    Hepatology; 2003 Aug; 38(2):335-44. PubMed ID: 12883477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
    Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
    Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides.
    Mutwiri GK; Nichani AK; Babiuk S; Babiuk LA
    J Control Release; 2004 May; 97(1):1-17. PubMed ID: 15147800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections.
    Zimmermann S; Dalpke A; Heeg K
    Int J Med Microbiol; 2008 Jan; 298(1-2):39-44. PubMed ID: 17716944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
    Zhang Z; Guo K; Schluesener HJ
    J Neuroimmunol; 2005 Apr; 161(1-2):68-77. PubMed ID: 15748945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling.
    Lim EJ; Lee SH; Lee JG; Chin BR; Bae YS; Kim JR; Lee CH; Baek SH
    FEBS Lett; 2006 Aug; 580(18):4533-8. PubMed ID: 16870179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of CpG-DNA against mastitis induced by Escherichia coli infection in a rat model.
    Zhu Y; Fan H; Miao J; Zou S
    Vet J; 2008 Mar; 175(3):369-78. PubMed ID: 17408997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of neutrophil elastase inhibitor (FR136706) in lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.
    Uchida Y; Kaibori M; Hijikawa T; Ishizaki M; Ozaki T; Tanaka H; Matsui K; Tokuhara K; Kwon AH; Kamiyama Y; Okumura T
    J Surg Res; 2008 Mar; 145(1):57-65. PubMed ID: 17936791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge.
    Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L
    Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG oligodeoxynucleotides protect mice from lethal challenge with Candida albicans via a pathway involving tumor necrosis factor-alpha-dependent interleukin-12 induction.
    Choi JH; Ko HM; Park SJ; Kim KJ; Kim SH; Im SY
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):155-62. PubMed ID: 17854477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling.
    Chen LW; Chang WJ; Chen PH; Liu WC; Hsu CM
    Shock; 2008 Nov; 30(5):563-70. PubMed ID: 18317407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.